32 year old investor...I really enjoy biotechnology stocks as they are right up my area of work. Was an industrial chemist for preclinical FDA studies currently employed as a board certified clinical pharmacotherapy specialists.
I am a retired computer scientist (HP) and am enjoying researching new medical treatments and the associated companies. I believe that carefully understanding and researching the underlying science will help understand the chance for success of clinical trials (side effects and key factors like delivery for mRNA).
`I am the Cat who walks by himself, and all places are alike to me.'
The individual has always had to struggle from being overwhelmed by the tribe. If you try it, you will be lonely often and sometimes frightened. But no price is too high to pay for the privilege of owning yourself.
Board Certified Physician
Individual Investor. Long Only. Interests, technology, healthcare.
private investor....former student in bio tech ....interested in advancing practical and economical sources of treatment for human welfare with dignity an awareness . methodical research can be done with new technology with a much more efficient an timely manner...especially vaccines developed thru research more than a decade ago....Why an Who is creating the lengthy timeline to get these cancer vaccines to patients....We can send discover satellites to another solar system an RETRIEVE the DATA ! WE as a generation are mapping our entire solar system an beyond...OUR government has a duty to protect its citizens not only by man/made laws, but the very law of NATURE demands accountability from its leaders....I am saddened by their methods.!
I am a Master Engineer I/Scientist working in the Aerospace industry. My 401 K money is mostly in stocks via funds. I trade biotech stocks with my discretionary funds (in my spare time). I do not short, but I will take gains over the short term.
2013 Performance: Weighted average gain per trade: 15%; Best Single Trade: 157% (KERX); Worst Single Trade: -84% (CLSN).
2014 Performance: Weighted average gain per trade: 12.6%; Best Single Trade: 112% (ASPX); Worst Single Trade: -91% (AFFY).
2015 Performance: Weighted average gain per trade: 13.2%; Best Single Trade: 79% (RMTI); Worst Single Trade: -93% (UNIS). If I had closed out all my positions on 12/31/15, my net return since account inception in 2011 would have been -7.2%. Ouch. But I'm planting seeds, right? Time will tell whether they grow into anything.